250 related articles for article (PubMed ID: 19373245)
1. NEMO/IKKgamma regulates an early NF-kappaB-independent cell-death checkpoint during TNF signaling.
Legarda-Addison D; Hase H; O'Donnell MA; Ting AT
Cell Death Differ; 2009 Sep; 16(9):1279-88. PubMed ID: 19373245
[TBL] [Abstract][Full Text] [Related]
2. NEMO inhibits programmed necrosis in an NFκB-independent manner by restraining RIP1.
O'Donnell MA; Hase H; Legarda D; Ting AT
PLoS One; 2012; 7(7):e41238. PubMed ID: 22848449
[TBL] [Abstract][Full Text] [Related]
3. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the NF-kappaB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-kappaB essential modulator NEMO.
Frelin C; Imbert V; Bottero V; Gonthier N; Samraj AK; Schulze-Osthoff K; Auberger P; Courtois G; Peyron JF
Cell Death Differ; 2008 Jan; 15(1):152-60. PubMed ID: 17932497
[TBL] [Abstract][Full Text] [Related]
5. Novel Phosphorylations of IKKγ/NEMO.
Lee SH; Toth Z; Wong LY; Brulois K; Nguyen J; Lee JY; Zandi E; Jung JU
mBio; 2012 Nov; 3(6):e00411-12. PubMed ID: 23131831
[TBL] [Abstract][Full Text] [Related]
6. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
[TBL] [Abstract][Full Text] [Related]
7. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
[TBL] [Abstract][Full Text] [Related]
8. PIDD mediates NF-kappaB activation in response to DNA damage.
Janssens S; Tinel A; Lippens S; Tschopp J
Cell; 2005 Dec; 123(6):1079-92. PubMed ID: 16360037
[TBL] [Abstract][Full Text] [Related]
9. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.
Mauro C; Pacifico F; Lavorgna A; Mellone S; Iannetti A; Acquaviva R; Formisano S; Vito P; Leonardi A
J Biol Chem; 2006 Jul; 281(27):18482-8. PubMed ID: 16684768
[TBL] [Abstract][Full Text] [Related]
10. RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.
Zhang L; Blackwell K; Workman LM; Chen S; Pope MR; Janz S; Habelhah H
Mol Cell Biol; 2015 Oct; 35(19):3324-38. PubMed ID: 26195820
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling.
O'Donnell MA; Legarda-Addison D; Skountzos P; Yeh WC; Ting AT
Curr Biol; 2007 Mar; 17(5):418-24. PubMed ID: 17306544
[TBL] [Abstract][Full Text] [Related]
12. NEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N-terminal 251 residues are sufficient for this process.
Tolani B; Matta H; Gopalakrishnan R; Punj V; Chaudhary PM
J Virol; 2014 Jun; 88(11):6345-54. PubMed ID: 24672029
[TBL] [Abstract][Full Text] [Related]
13. Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.
Togi S; Shiga K; Muromoto R; Kato M; Souma Y; Sekine Y; Kon S; Oritani K; Matsuda T
J Immunol; 2013 Aug; 191(3):1436-44. PubMed ID: 23817415
[TBL] [Abstract][Full Text] [Related]
14. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage.
Yang Y; Xia F; Hermance N; Mabb A; Simonson S; Morrissey S; Gandhi P; Munson M; Miyamoto S; Kelliher MA
Mol Cell Biol; 2011 Jul; 31(14):2774-86. PubMed ID: 21606198
[TBL] [Abstract][Full Text] [Related]
15. NEMO differentially regulates TCR and TNF-α induced NF-κB pathways and has an inhibitory role in TCR-induced NF-κB activation.
Wang K; Diao LH; Gong Y; Liu X; Li Y
Cell Signal; 2012 Aug; 24(8):1556-64. PubMed ID: 22513115
[TBL] [Abstract][Full Text] [Related]
16. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
17. A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.
He KL; Ting AT
Mol Cell Biol; 2002 Sep; 22(17):6034-45. PubMed ID: 12167698
[TBL] [Abstract][Full Text] [Related]
18. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8.
Ikner A; Ashkenazi A
J Biol Chem; 2011 Jun; 286(24):21546-54. PubMed ID: 21525013
[TBL] [Abstract][Full Text] [Related]
19. Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells.
Blonska M; You Y; Geleziunas R; Lin X
Mol Cell Biol; 2004 Dec; 24(24):10757-65. PubMed ID: 15572679
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.
Varfolomeev E; Izrael-Tomasevic A; Yu K; Bustos D; Goncharov T; Belmont LD; Masselot A; Bakalarski CE; Kirkpatrick DS; Vucic D
Biochem J; 2015 Feb; 466(1):45-54. PubMed ID: 25423073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]